Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes

被引：0
|
作者：
Patricia K Coyle
Bruce A Cohen
Thomas Leist
Clyde Markowitz
MerriKay Oleen-Burkey
Marc Schwartz
Mark J Tullman
Howard Zwibel
机构：
[1] Stony Brook University,Department of Neurology
[2] Health Sciences Center T12-020,Department of Neurology
[3] Northwestern University,Multiple Sclerosis Center at Penn
[4] Comprehensive MS Center,undefined
[5] Thomas Jefferson University,undefined
[6] University of Pennsylvania,undefined
[7] Health Outcomes Research Consulting and Writing,undefined
[8] Outcomes Scribe,undefined
[9] LLC,undefined
[10] Biostatistics,undefined
[11] MedNet Solutions,undefined
[12] Inc,undefined
[13] The MS Center for Innovations in Care,undefined
[14] Missouri Baptist Medical Center,undefined
[15] Neuroscience Consultants,undefined
[16] Comprehensive Multiple Sclerosis Center,undefined
来源：
BMC Neurology | / 14卷
关键词：
Multiple sclerosis; Disease-modifying therapy; Compliance; Relapses; Disability; Quality of life; Work productivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis What Is the Future of Multiple Sclerosis Treatment?
    Rjeily, Nicole Bou
    Mowry, Ellen M.
    Ontaneda, Daniel
    Carlson, Alise K.
    NEUROLOGIC CLINICS, 2024, 42 (01) : 185 - 201
  • [32] Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society
    Kulakowska, Alina
    Mirowska-Guzel, Dagmara
    Kalinowska, Alicja
    Bartosik-Psujek, Halina
    Brola, Waldemar
    Stasiolek, Mariusz
    Glabinski, Andrzej
    Losy, Jacek
    Potemkowski, Andrzej
    Rejdak, Konrad
    Sarzynska-Dlugosz, Iwona
    Siger, Malgorzata
    Stepien, Adam
    Wawrzyniak, Slawomir
    Zaborski, Jacek
    Zakrzewska-Pniewska, Beata
    Adamczyk-Sowa, Monika
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (06) : 569 - 585
  • [33] Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
    Kleiter, Ingo
    Lang, Michael
    Jeske, Judith
    Norenberg, Christiane
    Stollfuss, Barbara
    Schuerks, Markus
    BMC NEUROLOGY, 2017, 17
  • [34] The effect of exercise therapy on fatigue in multiple sclerosis
    Andreasen, A. K.
    Stenager, E.
    Dalgas, U.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (09) : 1041 - 1054
  • [35] Concepts of induction and escalation therapy in multiple sclerosis
    Rieckmann, Peter
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 277 : S42 - S45
  • [36] Interferon therapy of multiple sclerosis
    Jarius S.
    Hohlfeld R.
    Der Nervenarzt, 2004, 75 (12) : 1226 - 1229
  • [37] The future of multiple sclerosis therapy
    Kieseier, Bernd C.
    Wiendl, Heinz
    Hartung, Hans-Peter
    Stueve, Olaf
    PHARMACOLOGICAL RESEARCH, 2009, 60 (04) : 207 - 211
  • [38] Daclizumab Therapy for Multiple Sclerosis
    Bielekova, Bibiana
    NEUROTHERAPEUTICS, 2013, 10 (01) : 55 - 67
  • [39] Exercise therapy and multiple sclerosis: a systematic review
    Sa, Maria Jose
    JOURNAL OF NEUROLOGY, 2014, 261 (09) : 1651 - 1661
  • [40] Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon
    Chen, Chao
    Wu, Ning
    Watson, Crystal
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 723 - 730
12345